Weight loss drug patents ending, raising health concerns

Patents for weight loss drugs like Ozempic are set to expire by 2029, allowing generic versions to flood the market at significantly reduced prices. The availability of cheap generic alternatives raises concerns about misuse by people who don't medically require the drugs, particularly for cosmetic purposes. Medical experts warn about potential side effects including gastroparesis and weight regain after discontinuation, emphasising that these are medicines requiring proper medical supervision rather than cosmetic products.See omnystudio.com/listener for privacy information.